Maarten E. Emmelot
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Immunology top 10%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
- Immunology 12
- Immunotherapy and Immune Responses 9
- T-cell and B-cell Immunology 7
- Immune Cell Function and Interaction 7
-
- vaccines and immunoinformatics approaches 8
- Co-authors
- Tuna Mutis (14 shared papers)Leo F. Verdonck (3 shared papers)Tineke Aarts‐Riemens (4 shared papers)Anton C. Martens (5 shared papers)Henk M. Lokhorst (6 shared papers)Patricia Kaaijk (10 shared papers)Cécile A. C. M. van (10 shared papers)Monique C. Minnema (3 shared papers)
- Journals
- Blood (5 papers)Clinical Cancer Research (2 papers)Bone Marrow Transplantation (2 papers)Viruses (2 papers)Vaccines (2 papers)
- Partner nations
- NetherlandsUnited StatesCanada
In The Last Decade
Maarten E. Emmelot
24 papers receiving 530 citations
Peers
Comparison fields: 5 of 55
- Hematology 209
- Immunology 292
- Oncology 132
- Infectious Diseases 68
- Molecular Biology 166
Countries citing papers authored by Maarten E. Emmelot
This map shows the geographic impact of Maarten E. Emmelot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maarten E. Emmelot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maarten E. Emmelot more than expected).
Fields of papers citing papers by Maarten E. Emmelot
This network shows the impact of papers produced by Maarten E. Emmelot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maarten E. Emmelot. The network helps show where Maarten E. Emmelot may publish in the future.
Co-authors
The 25 scholars most cited alongside Maarten E. Emmelot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 139 | |
| 2 | 2008 | 82 | |
| 3 | 2006 | 79 | |
| 4 | 2008 | 35 | |
| 5 | 2014 | 35 | |
| 6 | 2016 | 24 | |
| 7 | 2013 | 22 | |
| 8 | 2022 | 20 | |
| 9 | 2022 | 19 | |
| 10 | 2015 | 17 | |
| 11 | 2022 | 11 | |
| 12 | 2019 | 11 | |
| 13 | 2019 | 10 | |
| 14 | Interleukin-17 production and T helper 17 cells in peripheral blood mononuclear cells in response to ocular lysate in patients with birdshot chorioretinopathy. | 2013 | 10 |
| 15 | 2016 | 8 | |
| 16 | 2021 | 3 | |
| 17 | 2021 | 3 | |
| 18 | 2011 | 2 | |
| 19 | 2025 | 1 | |
| 20 | 2005 | 1 |
About Maarten E. Emmelot
Maarten E. Emmelot is a scholar working on Immunology, Molecular Biology, Epidemiology, Oncology and Hematology, having authored 24 papers that have together received 536 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (9 papers), vaccines and immunoinformatics approaches (8 papers), T-cell and B-cell Immunology (7 papers), Immune Cell Function and Interaction (7 papers), Virology and Viral Diseases (7 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Multiple Myeloma Research and Treatments (4 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Hematology (209 citations), Immunology (292 citations), Oncology (132 citations), Infectious Diseases (68 citations) and Molecular Biology (166 citations). Maarten E. Emmelot has collaborated with scholars based in Netherlands, United States and Canada. Frequent co-authors include Tuna Mutis, Leo F. Verdonck, Tineke Aarts‐Riemens, Anton C. Martens, Henk M. Lokhorst, Patricia Kaaijk, Cécile A. C. M. van, Monique C. Minnema, Gerwin Huls and Jelle de Wit. Their work appears in journals such as Blood, Clinical Cancer Research, Bone Marrow Transplantation, Viruses and Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.